Prediction of environmental concentrations of glucocorticoids: The River Thames, UK, as an example

Environment International

Volumn 40, Issue 1, 2012, Pages 15-23

  Kugathas, Subramaniam ^a   Williams, Richard J ^b   Sumpter, John P ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

Author keywords

Glucocorticoid; Human pharmaceutical; Hydrocortisone; LowFlow2000 WQX

Indexed keywords

CHEMICAL ANALYSIS; EFFLUENT TREATMENT; EFFLUENTS; PHYSIOLOGY; RISK ASSESSMENT; RIVERS;

ANTI-INFLAMMATORIES; AQUATIC ENVIRONMENTS; AQUATIC ORGANISMS; DEVELOPED COUNTRIES; ENVIRONMENTAL CONCENTRATION; FIELD STUDIES; GLUCOCORTICOID; GLUCOCORTICOIDS; HIGH FLOW; HOT SPOT; HUMAN PHARMACEUTICAL; HYDROCORTISONE; IMMUNOSUPPRESSIVE DRUGS; LOW FLOW CONDITION; LOWFLOW2000-WQX; MEAN CONCENTRATIONS; RELIABLE ESTIMATES; REMOVAL RATE; RIVER THAMES; SEWAGE TREATMENT WORKS; SPATIAL AND TEMPORAL VARIATION; SYNTHETIC GLUCOCORTICOIDS;

SEWAGE TREATMENT PLANTS;

BECLOMETASONE; BETAMETHASONE; BUDESONIDE; CLOBETASOL; CORTISONE; DEXAMETHASONE; FLUTICASONE; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE; MOMETASONE FUROATE; PREDNISOLONE; PREDNISONE; SURFACE WATER; TRIAMCINOLONE;

CONCENTRATION (COMPOSITION); DRUG; MODELING; PREDICTION; RISK ASSESSMENT; RIVER WATER; SPATIAL VARIATION; TEMPORAL VARIATION; TOXICITY; WATER QUALITY;

ARTICLE; CONCENTRATION (PARAMETERS); EFFLUENT; POLLUTION MONITORING; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RIVER; SEWAGE TREATMENT; UNITED KINGDOM; WASTE COMPONENT REMOVAL; WATER FLOW; WATER POLLUTION;

ENGLAND; THAMES RIVER [ENGLAND]; UNITED KINGDOM;

EID: 84255195562     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2011.11.007     Document Type: Article

References (64)

1. Alder A.C., Schaffner C., Majewsky M., Klasmeier J., Fenner K. Fate of β-blocker human pharmaceuticals in surface water: comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland. Water Res 2010, 44:936-948.
2. Bahr N.I., Palme R., Möhle U., Hodges J.K., Heistermann M. Comparative aspects of the metabolism and excretion of cortisol in three individual nonhuman primates. Gen Comp Endocrinol 2000, 117:427-438.
3. Balaam J.L., Grover D., Johnson A.C., Jürgens M., Readman J., Smith A.J., et al. The use of modelling to predict levels of estrogens in a river catchment: how does modelled data compare with chemical analysis and in vitro yeast assay results?. Sci Total Environ 2010, 408:4826-4832.
4. BNF British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain 2006, 916.
5. Boobis A.R. Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide. Respir Med 1998, 92:2-6.
6. Bound J.P., Voulvoulis N. Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom. Environ Health Perspect 2005, 113:1705-1711.
7. Brian J.V., Harris C.A., Scholze M., Backhaus T., Booy P., Lamoree M., et al. Accurate prediction of the response of freshwater fish to a mixture of estrogenic chemicals. Environ Health Perspect 2005, 113:721-728.
8. Burkhardt-Holm P. Endocrine disruptors and water quality: a state-of-the-art review. Int J Water Resour Dev 2010, 26:477-493.
9. Caldwell D.J., Mastrocco F., Hutchinson T.H., Länge R., Heijerick D., Janssen C., et al. Derivation of an aquatic predicted no-effect concentration for the synthetic hormone, 17α-ethinyl estradiol. Environ Sci Technol 2008, 42:7046-7054.
10. Chang H., Hu J., Shao B. Occurrence of natural and synthetic glucocorticoids in sewage treatment plants and receiving river waters. Environ Sci Technol 2007, 41:3462-3468.
11. Chang H., Wan Y., Hu J. Determination and source apportionment of five classes of steroid hormones in urban rivers. Environ Sci Technol 2009, 43:7691-7698.
12. Corcoran J., Winter M.J., Tyler C.R. Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish. Crit Rev Toxicol 2010, 40:287-304.
13. Dai A. Drought under global warming: a review. Wiley Interdiscip Rev Clim Change 2010, 10.1002/wcc.81.
14. David D.S., Grieco M.H., Cushman P. Adrenal glucocorticoids after twenty years. A review of their clinically relevant consequences. J Chronic Dis 1970, 22:637-711.
15. Diaz-Nieto J., Wilby R.L. A comparison of statistical downscaling and climate change factor methods: impacts on low flows in the River Thames, United Kingdom. Clim Change 2005, 69:245-268.
16. Edsbacker S., Andersson P., Lindberg C. Liver metabolism of budesonide in rat, mouse, and man. Comparative aspects. Drug Metab Dispos 1987, 15:403-411.
17. EMEA European Medicines Agency: Guideline of the Environmental Risk assessment of Medicinal Products for Human Use 2006, EMEA, London, MEA/CHMP/SWP/4447/00.
18. Feher T., Koref O., Tanko A. Metabolism of a prednisolone compound in human under normal and pathological conditions. Arzneimittelforschung/Drug Res 1975, 25:1314-1317.
19. Goyal R.N., Bishnoi S. Simultaneous voltammetric determination of prednisone and prednisolone in human body fluids. Talanta 2009, 79:768-774.
20. Hannah R., D'Aco V.J., Anderson P.D., Buzby M.E., Caldwell D.J., Cunningham V.L., et al. Exposure assessment of 17α-ethinylestradiol in surface waters of the United States and Europe. Environ Toxicol Chem 2009, 28:2725-2732.
21. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 2002, 131:5-17.
22. Ingerslev F., Vaclavik E., Halling-Sørensen B. Pharmaceuticals and personal care products: a source of endocrine disruption in the environment?. Pure Appl Chem 2003, 75:1881-1893.
23. Jjemba P.K. Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicol Environ Saf 2006, 63:113-130.
24. Jobling S., Nolan M., Tyler C.R., Brighty G., Sumpter J.P. Widespread sexual disruption in wild fish. Environ Sci Technol 1998, 32:2498-2506.
25. Jobling S., Williams R., Johnson A., Taylor A., Gross-Sorokin M., Nolan M., et al. Predicted exposures to steroid estrogens in U.K. rivers correlate with widespread sexual disruption in wild fish populations. Environ Health Perspect 2006, 114(Suppl 1):32-39.
26. Johnson A.C. Natural variations in flow are critical in determining concentrations of point source contaminants in rivers: an estrogen example. Environ Sci Technol 2010, 44:7865-7870.
27. Johnson A.C., Sumpter J.P. Removal of endocrine-disrupting chemicals in activated sludge treatment works. Environ Sci Technol 2001, 35:4697-4703.
28. Johnson A.C., Williams R.J., Matthiessen P. The potential steroid hormone contribution of farm animals to freshwaters, the United Kingdom as a case study. Sci Total Environ 2006, 362:166-178.
29. Johnson A.C., Williams R.J., Simpson P., Kanda R. What difference might sewage treatment performance make to endocrine disruption in rivers?. Environ Pollut 2007, 147:194-202.
30. Johnson A.C., Ternes T., Williams R.J., Sumpter J.P. Assessing the concentrations of polar organic microcontaminants from point sources in the aquatic environment: measure or model?. Environ Sci Technol 2008, 42:5390-5399.
31. Johnson A.C., Jürgens M.D., Williams R.J., Kümmerer K., Kortenkamp A., Sumpter J.P. Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study. J Hydrol 2008, 348:167-175.
32. Keller V.D.J., Young A.R. Development of the Integrated Water Resources and Water Quality Modelling System. Science Report P2-248/SR. Environment Agency. Bristol, UK 2004.
33. Kugathas S., Sumpter J.P. Synthetic glucocorticoids in the environment: first results on their potential impacts on fish. Environ Sci Technol 2011, 45:2377-2383.
34. Liu Z.-, Kanjo Y., Mizutani S. Urinary excretion rates of natural estrogens and androgens from humans, and their occurrence and fate in the environment: a review. Sci Total Environ 2009, 407:4975-4985.
35. Mahajan A., Tandon V.R. Corticosteroids in rheumatology: friends or foes. J Indian Acad Clin Med 2005, 6:275-280.
36. Martinelli E., Ferrari P., Ripamonti A. Metabolism of deflazacort in the rat, dog and man. Drug Metab Dispos 1979, 7:335-339.
37. Maunder R.J., Matthiessen P., Sumpter J.P., Pottinger T.G. Rapid bioconcentration of steroids in the plasma of three-spined stickleback Gasterosteus aculeatus exposed to waterborne testosterone and 17β-oestradiol. J Fish Biol 2007, 70:678-690.
38. Melby J.C. Clinical pharmacology of systemic corticosteroids. Annu Rev Pharmacol Toxicol 1977, 17:511-527.
39. Möstl E., Messmann S., Bagu E., Robia C., Palme R. Measurement of glucocorticoid metabolite concentrations in faeces of domestic livestock. J Vet Med A Physiol Pathol Clin Med 1999, 46:621-631.
40. Munck A., Guyre P.M., Holbrook N.J. Physilogical functions of glucocorticoids in stress and their relations to pharmacological actions. Endocr Rev 1984, 5:25-44.
41. Paulos P., Runnalls T.J., Nallani G., La Point T., Scott A.P., Sumpter J.P., et al. Reproductive responses in fathead minnow and Japanese medaka following exposure to a synthetic progestin, Norethindrone. Aquat Toxicol 2010, 99:256-262.
42. Pickering A.D., Pottinger T.G. Stress responses and disease resistance in salmonid fish: effects of chronic elevation of plasma cortisol. Fish Physiol Biochem 1989, 7:253-258.
43. Piram A., Salvador A., Gauvrit J., Lanteri P., Faure R. Development and optimisation of a single extraction procedure for the LC/MS/MS analysis of two pharmaceutical classes residues in sewage treatment plant. Talanta 2008, 74:1463-1475.
44. Pozo O.J., Ventura R., Monfort N., Segura J., Delbeke F.T. Evaluation of different scan methods for the urinary detection of corticosteroid metabolites by liquid chromatography tandem mass spectrometry. J Mass Spectrom 2009, 44:929-944.
45. Price O.R., Williams R.J., Zhang Z., van Egmond R. Modelling concentrations of decamethylcyclopentasiloxane in two UK rivers using LF2000-WQX. Environ Pollut 2010, 158:356-360.
46. Price O.R., Williams R.J., van Egmond R., Wilkinson M.J., Whelan M.J. Predicting accurate and ecologically relevant regional scale concentrations of triclosan in rivers for use in higher-tier aquatic risk assessments. Environ Int 2010, 36:521-526.
47. Rhen T., Grissom S., Afshari C., Cidlowski J.A. Dexamethasone blocks the rapid biological effects of 17β-estradiol in the rat uterus without antagonizing its global genomic actions. FASEB J 2003, 17:1849-1870.
48. Rowney N.C., Johnson A.C., Williams R.J. Cytotoxic drugs in drinking water: a prediction and risk assessment exercise for the Thames catchment in the United Kingdom. Environ Toxicol Chem 2009, 28:2733-2743.
49. Runnalls T.J., Margiotta-Casaluci L., Kugathas S., Sumpter J.P. Pharmaceuticals in the aquatic environment: steroids and anti-steroids as high priorities for research. Hum Ecol Risk Assess 2010, 16:1318-1338.
50. Sanchez W., Sremski W., Piccini B., Palluel O., Maillot-Maréchal E., Betoulle S., et al. Adverse effects in wild fish living downstream from pharmaceutical manufacture discharges. Environ Int 2011, 37:1342-1348.
51. Sanderson H., Johnson D.J., Reitsma T., Brain R.A., Wilson C.J., Solomon K.R. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regul Toxicol Pharmacol 2004, 39:158-183.
52. Schriks M., Van Leerdam J.A., Van Der Linden S.C., Van Der Burg B., Van Wezel A.P., De Voogt P. High-resolution mass spectrometric identification and quantification of glucocorticoid compounds in various wastewaters in the Netherlands. Environ Sci Technol 2010, 44:4766-4774.
53. Sparagana M., Kucera L., Phillips G., Hoffmann C. Automated determination of urinary corticosteroids. Steroids 1970, 15:353-371.
54. Struijs J. SimpleTreat 3.0: a model to predict the distribution and elimination of chemicals by sewage treatment plants. National Institute of Public Health and Environmental Protection (RIVM), Bilthoven, the Netherlands 1996, Report Number 719101025.
55. Sumpter J.P., Johnson A.C. Lessons from endocrine disruption and their application to other issues concerning trace organics in the aquatic environment. Environ Sci Technol 2005, 39:4321-4332.
56. Sumpter J.P., Johnson A.C., Williams R.J., Kortenkamp A., Scholze M. Modeling effects of mixtures of endocrine disrupting chemicals at the river catchment scale. Environ Sci Technol 2006, 40:5478-5489.
57. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32:3245-3260.
58. Tölgyesi A., Verebey Z., Sharma V.K., Kovacsics L., Fekete J. Simultaneous determination of corticosteroids, androgens, and progesterone in river water by liquid chromatography-tandem mass spectrometry. Chemosphere 2010, 78:972-979.
59. Tong A.Y.C., Peake B.M., Braund R. Disposal practices for unused medications around the world. Environ Int 2010, 37(1):292-298.
60. Van Der Linden S.C., Heringa M.B., Man H.-, Sonneveld E., Puijker L.M., Brouwer A., et al. Detection of multiple hormonal activities in wastewater effluents and surface water, using a panel of steroid receptor CALUX bioassays. Environ Sci Technol 2008, 42:5814-5820.
61. Vulliet E., Baugros J.-, Flament-Waton M.-, Grenier-Loustalot M.- Analytical methods for the determination of selected steroid sex hormones and corticosteriods in wastewater. Anal Bioanal Chem 2007, 387:2143-2151.
62. Williams R.J., Johnson A.C., Smith J.J.L., Kanda R. Steroid estrogens profiles along river stretches arising from sewage treatment works discharges. Environ Sci Technol 2003, 37:1744-1750.
63. Williams R.J., Keller V.D.J., Johnson A.C., Young A.R., Holmes M.G.R., Wells C., et al. A national risk assessment for intersex in fish arising from steroid estrogens. Environ Toxicol Chem 2009, 28:220-230.
64. Zeilinger J., Steger-Hartmann T., Maser E., Goller S., Vonk R., Länge R. Effects of synthetic gestagens on fish reproduction. Environ Toxicol Chem 2009, 28:2663-2670.